Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01802203 · ClinicalTrials.gov registry record
trūFreeze® Spray Cryotherapy Patient Registry
A clinical trial of Barrett Esophagus and Esophageal Neoplasm, sponsored by US Endoscopy Group.
- Completed
- Registry status
- 275
- Enrollment target
- 16
- Study locations
NCT01802203 is a study of Barrett Esophagus and Esophageal Neoplasm that has completed, run by US Endoscopy Group. The registered enrollment target is 275 participants, below the 3,557-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (92% lower). The trial reports 16 study locations across 11 states.
The verdict
NCT01802203, a study of Barrett Esophagus and Esophageal Neoplasm, has completed, sponsored by US Endoscopy Group.
- COMPLETED
- Registry status
- 275 participants
- Enrollment target
- 16
- Study locations
Study Summary
To collect efficacy and outcomes data related to the use of trūFreeze® spray cryotherapy for the treatment of unwanted tissue in the pulmonary and gastrointestinal settings.
Conditions Studied
Interventions
- DEVICE truFreeze Spray Cryotherapy
Study Locations (16)
Massachusetts
- Massachusetts General Hosptial - Boston
- Boston University Medical Center - Boston
- Beth Israel Deaconess Medical Center - Boston
New York
- ProHEALTH Care Associates - Lake Success
- NYU - New York
- University of Rochester/Strong Memorial Medical Center - Rochester
Maryland
- University of Maryland - Baltimore
- Walter Reed National Military Medical Center - Bethesda
California
- Scripps Green Hosptial - La Jolla
Colorado
- University of Colorado Denver - Denver
Florida
- Borland-Groover Clinic - Jacksonville
Louisiana
- Ochsner Medical Center - Kenner
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 275 participants |
| Start Date | 2013-04 |
| Est. Completion | 2022-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01802203
The ClinicalTrials.gov registry entry for NCT01802203 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 275 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,557-participant average among 32 other Barrett Esophagus trials with a reported enrollment target (92% lower). The listed sponsor is US Endoscopy Group, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Barrett Esophagus appearing as the primary indexed condition, and to 1 intervention - of which truFreeze Spray Cryotherapy is the first listed.
NCT01802203 reports 16 study locations spanning 11 distinct geographic areas - top geographies include Massachusetts, New York, Maryland.
Frequently Asked Questions
What is clinical trial NCT01802203 about?
NCT01802203 is a clinical study titled "trūFreeze® Spray Cryotherapy Patient Registry". To collect efficacy and outcomes data related to the use of trūFreeze® spray cryotherapy for the treatment of unwanted tissue in the pulmonary and gastrointestinal settings.
What is the current status of trial NCT01802203?
This trial is currently completed. The enrollment target is 275 participants. The study started on 2013-04. Estimated completion is 2022-04.
What conditions does trial NCT01802203 study?
This clinical trial studies the following conditions: Barrett Esophagus, Esophageal Neoplasm, Esophageal Dysplasia, Esophageal Stenosis, Bronchial Neoplasm.
What interventions are being tested in trial NCT01802203?
The interventions under investigation include: truFreeze Spray Cryotherapy (DEVICE).
Who is sponsoring clinical trial NCT01802203?
This trial is sponsored by US Endoscopy Group, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01802203 being conducted?
This trial has 16 study locations across California, Colorado, Florida, Louisiana, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Barrett Esophagus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
RECRUITING · NA
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Longitudinal Oral Microbiome Sampling for BE
RECRUITING
-
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
RECRUITING · NA
-
Non-Endoscopic Detection of Barrett's Esophagus Using Methylation Biomarkers on EndoSign® Cell Collection Device Samples
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.